ALLIANCEBERNSTEIN L.P. - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$74,000
-61.7%
139,900
-10.7%
0.00%
Q4 2015$193,000
-15.7%
156,7000.0%0.00%
Q3 2015$229,000
-25.2%
156,7000.0%0.00%
Q2 2015$306,000
+15.9%
156,700
+7.5%
0.00%
Q1 2015$264,000
-23.3%
145,7500.0%0.00%
Q4 2014$344,000
-13.6%
145,750
-11.3%
0.00%
Q3 2014$398,000
-27.8%
164,300
-16.2%
0.00%
Q2 2014$551,000196,1000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,425,000$3,363,0002.66%
ACUTA CAPITAL PARTNERS, LLC 1,228,111$2,898,0001.96%
Sio Capital Management, LLC 505,000$1,192,0000.94%
RA Capital Management 2,500,000$5,900,0000.63%
SPHERA FUNDS MANAGEMENT LTD. 750,000$1,770,0000.30%
TFS CAPITAL LLC 1,295,744$3,058,0000.29%
EAGLE ASSET MANAGEMENT INC 12,713,051$30,002,0000.17%
JW Asset Management, LLC 52,271$123,0000.09%
Lombard Odier Asset Management (USA) Corp 501,444$1,183,0000.08%
First Heartland Consultants, Inc. 74,624$176,0000.07%
View complete list of CTI BIOPHARMA CORP shareholders